Nordics - Sweden

Mannheimer Swartling

More informationMore information

Mannheimer Swartling houses a ‘highly skilled’ practice, which acts for a diverse client base of medical device manufacturers, domestic and global pharma companies, and innovation focused healthcare providers. The ‘superb’ Camilla Appelgren leads the team, and is well known for advising on a range of regulatory matters, including cases against national agencies concerning pricing and reimbursement, market access, and clinical trials. ‘Very wise adviser’ Peter Nilsson has notable knowledge surrounding trial subject data issues and research projects, having assisted numerous healthcare and pharma clients. Emmie Montgomery is particularly adept at advising clients on the processing of patient data, in addition to advertisement-related issues.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Camilla Appelgren possesses a deep understanding of her field, demonstrating quick thinking and offering well-balanced advice. We value her professionalism and personal touch.’

  • ‘Top tier team with an extensive knowledge within the life science area.’

  • ‘Mannheimer Swartling always puts together a tight team, ensuring the right expertise for the topic at hand. They have deep experience within Pharma/Life Sciences with broad competences. It has always been easy to work with Mannheimer on challenging and complex issues - and the team has offered expert advice in a timely fashion.’

  • ‘Peter Nilsson is probably the best lawyer I have across the region. He is an expert, extremely competent, and always ready to go the extra mile to help the clients. He is passionate.’

  • ‘Highly skilled professionals, who demonstrate good understanding of complex issues, including scientific evidence. Very strong collaboration with business stakeholders.’

  • ‘Camilla Appelgren is a superb lawyer, with a wealth of experience, and is a real pleasure to deal with.’

  • ‘Peter Nilsson, will surely be the next partner in line if this is what his heart desires. Very read up on new therapies, understands how modern drugs work, commercial challenges - very wise adviser!’

  • ‘Biggest life sciences practice in Sweden. In-depth knowledge of the sector. Very client-oriented. High quality advice. Also very good for litigation in that sector.’

Key clients

  • Bristol-Myers Squibb
  • Celgene
  • Swedish Orphan Biovitrum AB
  • AbbVie AB
  • Inceptua S.A.
  • Lipum AB
  • Capio AB
  • Capio S:t Görans Sjukhus AB
  • Camurus AB
  • Janssen-Cilag
  • Amgen
  • Humana Assistans AB

Work highlights

  • Represented Humana Assistans AB in major administrative court proceedings to challenge and set aside a decision by the Swedish Health and Social Care Inspectorate to revoke Humana’s operating permit.
  • Assisting BMS and Celgene (a BMS group company) with regulatory, commercial, pricing and reimbursement, and compliance matters.
  • Advised Impilo on its acquisition of Decon Wheel AB and VaccinDirekt.

Practice head

The lawyer(s) leading their teams.

Camilla Appelgren

Other key lawyers

Peter Nilsson, Emmie Montgomery